THERAPY DOSSIER · th-9bf3e9a4f372

Powdered dried seeds of Salicornia ramosissima

Nutraceutical

Evidence & regulatory context

Mechanism: Not recorded
Target: Not recorded
Injury models: Chemical/toxin
Reported indication: Not recorded
First approval: Not recorded
Development stage: Not recorded
ChEMBL record: Not recorded
ChEMBL max phase: Not recorded
Synonyms: Not recorded
Note: Not recorded

Clinical trials 1

0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.

NCT06076122 ↗NAunknown

Halophyte Plants (Salicornia extracts) as a Dietary Supplement to Improve Neurovascular Health

Ischemic Stroke

Enrolment: 350 · Results not recorded

Preclinical evidence 1

1 studies reported at therapy level; 1 evidence entries itemised.

PMID 30098546 ↗2018Reported harm

Salicornia ramosissima J. Woods seeds affected the normal regenerative function on carbon tetrachloride-induced liver and kidney injury.

MouseChemical/toxinMaleOral2000 mg/kg/dayAdministered before carbon tetrachloride in the protection setting and after ca…

Model: Carbon tetrachloride-induced acute liver and kidney injury (0.2 mL/kg), studied as seed effects alone, protection against acute carbon tetrachloride toxicity, and regeneration after acute carbon tetrachloride exposure

Seed powder alone produced slightly enlarged hepatic sinusoids and noticeable renal inflammation, gave no protection against carbon tetrachloride toxicity and did not aid hepatic or renal recovery, with the authors reporting apparent synergism between the seeds and carbon tetrachloride under these…

Extraction: extract · Supplied extraction confidence: 0.7. Machine-extracted fields require source verification.

Loading the evidence…